Kelvin Memeh, MD, MS, MBA, FACS
Endocrine Surgical Oncologist. Healthcare Economist. Surgical Outcomes Researcher
Welcome! I'm a board-certified surgeon specialising in endocrine surgery and surgical oncology — which means I treat cancers and diseases of the thyroid, parathyroid, adrenal glands, and related tumours. I currently practise at the OSUCCC – James, The Ohio State University Comprehensive Cancer Center, one of the nation's leading cancer hospitals.
I was born and raised in Nigeria, where I completed my medical training at the University of Benin. That foundation shaped my deep belief that good medicine should be accessible to everyone — wherever they live and whatever their background. I am happily married and my family is my greatest source of strength and joy.
Beyond the operating room, I love photography and art, traveling the world, a really good cup of coffee, and exploring the latest technology. These pursuits keep me grounded, curious, and connected to life outside the hospital.
My work sits at the intersection of surgical science and healthcare policy. I use large national datasets to ask hard questions: Does where you receive surgery affect whether you survive? Does your weight change your surgical risk? Should we always operate, or are there better options? I believe evidence-based answers to these questions directly improve patient care.
I trained at The University of Chicago, where I developed a deep focus on endocrine oncology and healthcare economics. I am committed to advancing world-class surgical care while championing rigorous research to optimise our healthcare system.
Areas of Expertise
Get in Touch
✉ info@kelvinmemeh.comResearch & Scholarship
My Publications
I have summarised my research findings in easy-to-follow language so everyone can understand them and why they matter.
Thyroid Disease
Association of Obesity and Thyroidectomy-Specific Perioperative Outcomes
What this research means for you
A thyroidectomy is surgery to remove all or part of the thyroid gland — the butterfly-shaped gland in your neck that controls your metabolism. As obesity becomes more common, surgeons need to understand how a patient's weight affects the specific risks of this operation.
Using a large national dataset of thousands of thyroid surgery patients, the research team found something nuanced: obese patients were actually less likely to develop low calcium levels after surgery (a common complication), but they were more likely to experience voice hoarseness and neck haematoma — a pooling of blood in the neck that can require a return to the operating room.
Why it matters: Surgeons can now counsel patients with obesity more accurately before their operation, plan for extra precautions, and ensure closer post-operative monitoring for the complications most likely to affect them.
Practice Variations, Trends, and Outcomes of Drain Use in Thyroidectomy: A NSQIP Study
What this research means for you
After thyroid surgery, surgeons sometimes place a small tube — a drain — in the neck to collect fluid. Does this drain actually help, or does it just keep patients in hospital longer?
Analysing thousands of thyroid surgeries nationwide, the team found that surgical drains do not reduce the risk of dangerous neck bleeding and don't prevent the need for emergency re-operation. But they do significantly increase hospital stay. A striking practice gap was also revealed: ENT surgeons use drains far more often than general surgeons — despite similar outcomes.
Why it matters: Routine drains after thyroidectomy may be unnecessary for most patients — meaning shorter hospital stays and faster recovery without added risk.
A Machine-Learning Algorithm for Distinguishing Malignant from Benign Indeterminate Thyroid Nodules Using Ultrasound Radiomic Features
What this research means for you
Thyroid nodules — small lumps in the thyroid gland — are extremely common. Most are completely harmless, but some are cancerous. When a biopsy comes back with an uncertain ("indeterminate") result, it creates a dilemma: operate and risk unnecessary surgery, or wait and risk missing a cancer?
This study used artificial intelligence (machine learning) to analyse ultrasound images of thyroid nodules in detail — picking up subtle patterns invisible to the human eye. The algorithm correctly identified cancerous vs. non-cancerous nodules with an accuracy rate (AUC of 0.88) that outperformed a widely used commercial molecular test (AUC 0.81).
Why it matters: A smarter, AI-powered tool for reading ultrasound scans could mean fewer unnecessary surgeries, faster peace of mind for patients, and more precise cancer detection — all from an imaging test that's already routine.
Adrenal Disease
Clinical Significance of Pheochromocytoma Size on the Timing and Extent of Surgery
What this research means for you
A pheochromocytoma is a tumour growing on the adrenal glands — small organs that sit on top of your kidneys — that can cause dangerous spikes in blood pressure, a racing heart, and sweating. Doctors know these tumours need to be surgically removed, but knowing when to operate has always been tricky.
This study followed 63 patients and found that tumours measuring 2.3 centimetres or larger produced significantly higher hormone levels — meaning more symptoms and more cardiovascular risk. Hormonal output roughly tripled with every doubling of tumour size. Surprisingly, symptoms alone were not a reliable guide.
Why it matters: These findings give surgeons a measurable, objective way to judge urgency. Patients with tumours at or above 2.3 cm may benefit from faster scheduling and more thorough pre-operative blood pressure control — making surgery safer.
Survival Impact of Treatment Utilisation and Margin Status After Resection of Adrenocortical Carcinoma
What this research means for you
Adrenocortical carcinoma is a rare and aggressive cancer of the adrenal gland. When surgeons operate to remove it, one critical factor is whether they achieve "clear margins" — meaning no cancer cells are left at the edges of what was removed. But what actually happens to patients when the margins aren't clean?
Analysing over 15 years of national cancer data, this study found that one in three patients had cancer cells at the surgical margins after their operation. Patients with positive margins survived, on average, 15.6 months less than those with clear margins. Encouragingly, the impact of positive margins on survival has been improving over time — likely due to better use of additional (adjuvant) therapies after surgery.
Why it matters: This research underscores the importance of operating at high-volume, experienced centres and highlights that adjuvant therapy after surgery can meaningfully improve survival even when margins are not clear.
Neuroendocrine Tumours
Morbidity and Outcomes of Primary Tumour Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumours
What this research means for you
Neuroendocrine tumours (NETs) of the small intestine are slow-growing cancers that can spread to the liver and other organs. When the cancer has already spread widely, should surgeons still remove the original tumour — or is medical management just as effective?
This study followed 180 patients over nearly 10 years. Removing the primary tumour upfront did not meaningfully improve survival compared to medical management alone. However, patients who later needed emergency surgery — because the tumour caused a bowel obstruction — had a seven-fold increase in mortality risk.
Why it matters: All patients with these tumours need careful, regular monitoring regardless of initial treatment. Catching complications early is what saves lives — not necessarily rushing to the operating room at the outset.
Surgical Treatment of Non-Functioning Pancreatic Neuroendocrine Tumours: Current Controversies and Challenges
What this research means for you
Pancreatic neuroendocrine tumours are unusual growths in the pancreas. "Non-functioning" means they produce no hormonal symptoms, so they're often discovered accidentally during scans done for other reasons — creating a real dilemma: should a tumour that isn't causing any symptoms be removed?
This review tackled three key questions: Should small tumours under 2 cm be removed? When the cancer has spread, does surgery still help? And if the cancer can't be fully removed, is partial removal worthwhile? After reviewing the best available evidence, the authors found support for a more active surgical approach, because these tumours can grow silently and spread if left unchecked.
Why it matters: This paper shapes how surgeons counsel patients who receive an unexpected finding on a scan. Most patients are better off having the tumour removed — even when they feel perfectly well — to prevent worse outcomes later.
Treatment at Academic Facilities Is Associated With Improved Survival in Late-Stage Colonic Neuroendocrine Tumours
What this research means for you
Where you receive cancer treatment can matter just as much as what treatment you receive. This study asked a direct question: does being treated at a large academic hospital — versus a community hospital — improve survival for patients with advanced colon neuroendocrine tumours?
Using national cancer data from 2004 to 2021, the researchers compared outcomes at academic versus non-academic facilities. The answer was clear: patients treated at academic medical centres lived longer. These centres have specialised tumour boards, rare cancer expertise, advanced imaging, and multidisciplinary teams — all of which make a measurable difference in outcomes for this uncommon cancer.
Why it matters: It highlights that not all hospitals are equal when it comes to rare cancers, making a compelling case for ensuring patients with complex conditions can access high-volume specialised centres. Equity in access to specialised care could save lives.
Organisational Resources in Rare Cancer Outcomes: Survival Analysis After Surgery for Pheochromocytoma and Paraganglioma
What this research means for you
Pheochromocytomas and paragangliomas are rare tumours of the adrenal glands and related nerve tissue. Because they're uncommon, not every hospital has deep experience treating them. Does the type of hospital where you have surgery affect whether you survive?
This study examined hospital-level factors — academic status, available technology, surgical volume, and specialised staff — and their influence on survival after surgery. Patients operated on at better-resourced hospitals had significantly better outcomes. Teaching hospitals with high surgical volumes consistently outperformed lower-resource facilities.
Why it matters: For rare and complex conditions, the "system" around your surgeon matters enormously. This research supports policies encouraging referral of rare-cancer patients to specialised high-volume centres — and highlights the urgent need to reduce survival disparities driven by geography.
Thyroidectomy for Euthyroid Patients with Hashimoto Thyroiditis and Persisting Symptoms: A Cost-Effectiveness Analysis
What this research means for you
Hashimoto's thyroiditis is an autoimmune condition where the body attacks its own thyroid gland. Some patients continue experiencing debilitating symptoms — fatigue, joint pain, brain fog — even though their thyroid hormone levels are technically normal ("euthyroid"). For these patients, is surgery a reasonable and cost-effective solution?
This cost-effectiveness analysis found that total thyroidectomy is actually more cost-effective than long-term medical therapy alone for this group of patients — meaning it delivers better value for money per year of healthy life gained. However, the study also highlighted that complication rates from this surgery are considerably higher in Hashimoto's patients, and could increase dramatically if the procedure became widely adopted.
Why it matters: This paper helps doctors and patients weigh up the risks and costs of surgery versus lifelong medication for a condition that significantly impacts quality of life. It encourages careful, personalised decision-making rather than a one-size-fits-all approach.
Book Chapters Coming Soon
Details of Dr. Memeh's book chapters and contributions to surgical textbooks will be added here shortly. Check back soon.
Current Research
On-going Project
Coming Soon
Details of Dr. Memeh's current and on-going research projects will be shared here shortly. Stay tuned.
Patient Care
Clinical work
Coming Soon
Details about Dr. Memeh's clinical practice, conditions he treats, and how to book a consultation are on their way.
Perspectives & Insights
Blog
Posts Coming Soon
Dr. Memeh will be sharing thoughts on endocrine surgery, healthcare innovation, and life in surgery. Check back soon.
Photography & Moments
Gallery
Coming Soon
Photos and visual stories from Dr. Memeh's travels, work, and creative pursuits will live here soon.